Zhao-Hui Jin

4PUBLICATIONS
8CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersInstruments and techniques
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Feb 10, 2025
Evaluation of the Gly-Phe-Lys Linker to Reduce the Renal Radioactivity of a [64Cu]Cu-Labeled Multimeric cRGD Peptide.

Zhao-Hui Jin, Mélissa Degardin, Takako Furukawa

|Nov 11, 2022
Multiplexed Imaging Reveals the Spatial Relationship of the Extracellular Acidity-Targeting pHLIP with Necrosis, Hypoxia, and the Integrin-Targeting cRGD Peptide.

Zhao-Hui Jin, Atsushi B Tsuji, Mélissa Degardin

|Sep 16, 2020
Radiotheranostic Agent 64Cu-cyclam-RAFT-c(-RGDfK-)4 for Management of Peritoneal Metastasis in Ovarian Cancer.

Zhao-Hui Jin, Atsushi B Tsuji, Mélissa Degardin

|Jun 21, 2018
Uniform intratumoral distribution of radioactivity produced using two different radioagents, 64Cu-cyclam-RAFT-c(-RGDfK-)4 and 64Cu-ATSM, improves therapeutic efficacy in a small animal tumor model.

Zhao-Hui Jin, Atsushi B Tsuji, Mélissa Degardin

Pageof 1

Frequent Collaborators

3 joint publications

Atsushi B Tsuji

2 joint publications

Didier Boturyn

1 joint publications

Satoshi Obara

1 joint publications

Pascal Dumy